https://www.selleckchem.com/pr....oducts/GSK1904529A.h
Translational failures in anti-adhesion molecule therapies after stroke reveal the necessity of developing new strategies that not only interrupt leukocyte recruitment but also consider the inhibition of endothelial cell inflammation, verification of therapeutic time window, and normal function maintenance of circulating leukocytes. Our study focused on the potential therapeutic value of CD151 downregulation in improving current anti-adhesion molecule therapies. Lentivirus intracerebroventricular administration was conducted to inhi
إعجاب
علق
شارك
